{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:24:59Z","timestamp":1768206299859,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,11]]},"DOI":"10.7759\/cureus.101309","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:29:55Z","timestamp":1768195795000},"source":"Crossref","is-referenced-by-count":0,"title":["Refractory Intrahepatic Cholestasis of Pregnancy in Twin Gestation Managed With Ursodeoxycholic Acid and Adjunctive Cholestyramine: A Case Report"],"prefix":"10.7759","author":[{"given":"Samah A","family":"ElSalem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadia","family":"Mehmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afif","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muna","family":"Al-Saadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.2049","article-title":"Intrahepatic cholestasis of pregnancy","volume":"15","author":"Geenes V","year":"2009","unstructured":"Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2009, 15:2049-66. 10.3748\/wjg.15.2049","journal-title":"World J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2016.02.004","article-title":"Intrahepatic cholestasis of pregnancy: recent advances","volume":"34","author":"Ovadia C","year":"2016","unstructured":"Ovadia C, Williamson C. Intrahepatic cholestasis of pregnancy: recent advances. Clin Dermatol. 2016, 34:327-34. 10.1016\/j.clindermatol.2016.02.004","journal-title":"Clin Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31877-4","article-title":"Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses","volume":"393","author":"Ovadia C","year":"2019","unstructured":"Ovadia C, Seed PT, Sklavounos A, et al.. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet. 2019, 393:899-909. 10.1016\/S0140-6736(18)31877-4","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11626-x","article-title":"An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy","volume":"7","author":"Dixon PH","year":"2017","unstructured":"Dixon PH, Sambrotta M, Chambers J, et al.. An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy. Sci Rep. 2017, 7:11823. 10.1038\/s41598-017-11626-x","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1002\/hep.22139","article-title":"Sex hormones and bile acids in intrahepatic cholestasis of pregnancy","volume":"47","author":"Reyes H","year":"2008","unstructured":"Reyes H. Sex hormones and bile acids in intrahepatic cholestasis of pregnancy. Hepatology. 2008, 47:376-9.","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31270-X","article-title":"Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial","volume":"394","author":"Chappell LC","year":"2019","unstructured":"Chappell LC, Bell JL, Smith A, et al.. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet. 2019, 394:849-60. 10.1016\/S0140-6736(19)31270-X","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17206","article-title":"Intrahepatic cholestasis of pregnancy: Green-top guideline no. 43 June 2022","volume":"129","author":"Girling J","year":"2022","unstructured":"Girling J, Knight CL, Chappell L. Intrahepatic cholestasis of pregnancy: Green-top guideline no. 43 June 2022. BJOG. 2022, 129:e95-e114. 10.1111\/1471-0528.17206","journal-title":"BJOG"},{"key":"ref8","unstructured":"UKTIS. Use of rifampicin in pregnancy. (2023). https.\/\/uktis.org\/monographs\/use-of-rifampicin-in-pregnancy\/?utm_source=chatgpt.com."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2015.03.020","article-title":"Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy","volume":"189","author":"Geenes V","year":"2015","unstructured":"Geenes V, Chambers J, Khurana R, et al.. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy. Eur J Obstet Gynecol Reprod Biol. 2015, 189:59-63. 10.1016\/j.ejogrb.2015.03.020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20336","article-title":"Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates","volume":"40","author":"Glantz A","year":"2004","unstructured":"Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology. 2004, 40:467-74. 10.1002\/hep.20336","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1258\/0004563021901856","article-title":"Role of bile acid measurement in pregnancy","volume":"39","author":"Walker IA","year":"2002","unstructured":"Walker IA, Nelson-Piercy C, Williamson C. Role of bile acid measurement in pregnancy. Ann Clin Biochem. 2002, 39:105-13. 10.1258\/0004563021901856","journal-title":"Ann Clin Biochem"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80146-8","article-title":"Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo","volume":"27","author":"Palma J","year":"1997","unstructured":"Palma J, Reyes H, Ribalta J, et al.. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol. 1997, 27:1022-8. 10.1016\/S0168-8278(97)80146-8","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.113971","article-title":"Intra\u2011hepatic cholestasis of pregnancy: a comprehensive review","volume":"58","author":"Ghosh S","year":"2013","unstructured":"Ghosh S, Chaudhuri S. Intra\u2011hepatic cholestasis of pregnancy: a comprehensive review. Indian J Dermatol. 2013, 58:327. 10.4103\/0019-5154.113971","journal-title":"Indian J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2024.102618","article-title":"Guideline no. 452: diagnosis and management of intrahepatic cholestasis of pregnancy","volume":"46","author":"Hobson SR","year":"2024","unstructured":"Hobson SR, Cohen ER, Gandhi S, Jain V, Niles KM, Roy-Lacroix M\u00c8, Wo BL. Guideline no. 452: diagnosis and management of intrahepatic cholestasis of pregnancy. J Obstet Gynaecol Can. 2024, 46:102618. 10.1016\/j.jogc.2024.102618","journal-title":"J Obstet Gynaecol Can"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2013.783810","article-title":"Intrahepatic cholestasis of pregnancy: new insights into its pathogenesis","volume":"26","author":"Floreani A","year":"2013","unstructured":"Floreani A, Caroli D, Lazzari R, et al.. Intrahepatic cholestasis of pregnancy: new insights into its pathogenesis. J Matern Fetal Neonatal Med. 2013, 26:1410-5. 10.3109\/14767058.2013.783810","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1258\/om.2008.080010","article-title":"The molecular genetics of intrahepatic cholestasis of pregnancy","volume":"1","author":"Dixon PH","year":"2008","unstructured":"Dixon PH, Williamson C. The molecular genetics of intrahepatic cholestasis of pregnancy. Obstet Med. 2008, 1:65-71. 10.1258\/om.2008.080010","journal-title":"Obstet Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/a-1386-3912","article-title":"Management of intrahepatic cholestasis of pregnancy: recommendations of the Working Group on Obstetrics and Prenatal Medicine-section on maternal disorders","volume":"81","author":"Hagenbeck C","year":"2021","unstructured":"Hagenbeck C, Hamza A, Kehl S, et al.. Management of intrahepatic cholestasis of pregnancy: recommendations of the Working Group on Obstetrics and Prenatal Medicine-section on maternal disorders. Geburtshilfe Frauenheilkd. 2021, 81:922-39. 10.1055\/a-1386-3912","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.019","article-title":"Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy","volume":"129","author":"Kondrackiene J","year":"2005","unstructured":"Kondrackiene J, Beuers U, Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology. 2005, 129:894-901. 10.1053\/j.gastro.2005.06.019","journal-title":"Gastroenterology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000493.pub3","article-title":"Pharmacological interventions for treating intrahepatic cholestasis of pregnancy","volume":"7","author":"Walker KF","year":"2020","unstructured":"Walker KF, Chappell LC, Hague WM, Middleton P, Thornton JG. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy. Cochrane Database Syst Rev. 2020, 7:CD000493. 10.1002\/14651858.CD000493.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref20","unstructured":"Cholestyramine. drug information. (2025). https:\/\/www.uptodate.com\/contents\/cholestyramine-drug-information."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/441318-refractory-intrahepatic-cholestasis-of-pregnancy-in-twin-gestation-managed-with-ursodeoxycholic-acid-and-adjunctive-cholestyramine-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:29:56Z","timestamp":1768195796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/441318-refractory-intrahepatic-cholestasis-of-pregnancy-in-twin-gestation-managed-with-ursodeoxycholic-acid-and-adjunctive-cholestyramine-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,11]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.101309","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,11]]}}}